Imlifidase for the treatment of anti-HLA antibody-mediated processes in kidney transplantation.

Huang, Edmund; Maldonado, Angela Q; Kjellman, Christian; Jordan, Stanley C

Huang, Edmund; Maldonado, Angela Q; Kjellman, Christian; Jordan, Stanley C.

Afiliação

Huang E; Department of Medicine, Division of Nephrology, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Maldonado AQ; Hansa Biopharma, Lund, Sweden.
Kjellman C; Hansa Biopharma, Lund, Sweden.
Jordan SC; Department of Medicine, Division of Nephrology, Transplant Immunotherapy Program, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Am J Transplant ; 22(3): 691-697, 2022 03.

Article em En | MEDLINE | ID: mdl-34467625

Assuntos

Transplante de Rim; Soro Antilinfocitário; Rejeição de Enxerto/etiologia; Rejeição de Enxerto/prevenção & controle; Antígenos HLA; Humanos; Imunoglobulina G; Imunossupressores; Doadores de Tecidos

Palavras-chave

alloantibody; clinical research; desensitization; immune modulation; immunosuppressant - other; immunosuppression; kidney transplantation; nephrology; practice; rejection: antibody-mediated (ABMR); sensitization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google